Your search for supplemental oxygen returned 41 results

Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19

Lower average oxygen delivery rates seen in association with Asian, Black, Hispanic versus White race, ethnicity

Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air

No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen

Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients.

Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo

Current evidence indicates that a 6mg dose of dexamethasone daily is effective for improving COVID-19 outcomes among patients receiving supplemental oxygen.

The studies evaluated routine clinical practice data from more than 800 hospitals in the US.

Investigators evaluated the relationship between atopic dermatitis and frequency of severity markers in patients hospitalized with COVID-19.

Researchers find oxygen therapy does not improve quality of life, forestall hospitalization, lengthen lives